Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Venner

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
Journal of Magnetic Resonance Imaging : JMRI|June 13, 2023
Evaluating a Phase-Specific Approach to Aortic Flow: A 4D Flow MRI StudyMitch J F G Ramaekers, Jos J M Westenberg, Max F G H M Venner, et al.
Ebiomedicine|October 19, 2016
Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan AfricaColin M Venner, Immaculate Nankya, Fred Kyeyune, et al.
International Journal of Cardiology|April 4, 2025
Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensationMax F G H M Venner, Tom J G Gevers, Fabienne Ploum, et al.
Scientific Reports|March 11, 2025
Relating the molecular phenotype of ulcerative colitis to the clinical courseKatelynn S Madill-Thomsen, Jeffery M Venner, Denise E Parsons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancerHoward I Scher, Xiaoyu Jia, Kim Chi, et al.
Current Oncology (Toronto, Ont.)|October 5, 2011
Progression-free survival as a clinical trial endpoint in advanced renal cell carcinomaS J Hotte, G A Bjarnason, D Y C Heng, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 9, 2025
Predictive value of ambulatory ECG monitoring for malignant arrhythmic events in genetic dilated cardiomyopathyMax F G H M Venner, Astrid B M Heymans, Nina J Beelen, et al.
Circulation|February 3, 2017
Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart RejectionAlexandre Loupy, Jean Paul Duong Van Huyen, Luis Hidalgo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2007
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT InvestigatorsTomasz M Beer, Christopher W Ryan, Peter M Venner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trialGeorg A Bjarnason, Jennifer J Knox, Christian K Kollmannsberger, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
Journal of Magnetic Resonance Imaging : JMRI|June 13, 2023
Evaluating a Phase-Specific Approach to Aortic Flow: A 4D Flow MRI StudyMitch J F G Ramaekers, Jos J M Westenberg, Max F G H M Venner, et al.
Ebiomedicine|October 19, 2016
Infecting HIV-1 Subtype Predicts Disease Progression in Women of Sub-Saharan AfricaColin M Venner, Immaculate Nankya, Fred Kyeyune, et al.
International Journal of Cardiology|April 4, 2025
Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensationMax F G H M Venner, Tom J G Gevers, Fabienne Ploum, et al.
Scientific Reports|March 11, 2025
Relating the molecular phenotype of ulcerative colitis to the clinical courseKatelynn S Madill-Thomsen, Jeffery M Venner, Denise E Parsons, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 13, 2011
Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancerHoward I Scher, Xiaoyu Jia, Kim Chi, et al.
Current Oncology (Toronto, Ont.)|October 5, 2011
Progression-free survival as a clinical trial endpoint in advanced renal cell carcinomaS J Hotte, G A Bjarnason, D Y C Heng, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 9, 2025
Predictive value of ambulatory ECG monitoring for malignant arrhythmic events in genetic dilated cardiomyopathyMax F G H M Venner, Astrid B M Heymans, Nina J Beelen, et al.
Circulation|February 3, 2017
Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart RejectionAlexandre Loupy, Jean Paul Duong Van Huyen, Luis Hidalgo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 20, 2007
Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT InvestigatorsTomasz M Beer, Christopher W Ryan, Peter M Venner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 17, 2019
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trialGeorg A Bjarnason, Jennifer J Knox, Christian K Kollmannsberger, et al.
Pageof 10